ChromaVision Names Jose de la Torre-Bueno, Ph.D., Vice President, Research & Development.SAN JUAN CAPISTRANO San Juan Capistrano (săn wän kăpĭsträ`nō), city (1990 pop. 26,183), Orange co., S Calif.; inc. 1961. San Juan Capistrano has some manufactures, including aircraft parts, medical apparatus, and boats, but the economy is , Calif.--(BUSINESS WIRE)--Feb. 26, 1999-- ChromaVision Medical Systems Inc. (Nasdaq/NM: CVSN), a unique cellular imaging diagnostics company and manufacturer of the Automated Cellular Imaging System (ACIS(TM)), Friday announced the appointment of Jose de la Torre-Bueno, Ph.D., 50, to the position of vice president of Research and Development. Dr. Torre-Bueno joined ChromaVision as senior applications engineer in July of 1998, bringing an impressive background in image analysis, programming and biology. His significant contributions and leadership experience were immediately recognized, making him an excellent candidate to head the product development group. Torre-Bueno has been an inventor on two issued patents and one pending patent, and has assigned the rights for two additional inventions to ChromaVision. Additionally, he was the University of California, San Diego UCSD is consistently ranked among the top ten public universities for undergraduate education in the United States by U.S. News & World Report.[3] It is a Public Ivy. [1] For graduate studies, most of UCSD's Ph.D. "Connect" award winner for most innovative new product in 1991 for the Omnichrome-9 Full-Color Clinical Diagnostic System. "Jose is a proven R&D innovator and brings an exceptionally relevant background to ChromaVision. In his experience, he has taken numerous products from concept stage to market viability, and has played an integral role in all phases of product development and design," said ChromaVision Chief Executive Officer & President Douglas S. Harrington, M.D. "We are delighted to have Jose as a part of our executive team." Prior to joining ChromaVision, Torre-Bueno was engaged as a consultant to Tower Technologies in Encinitas, Calif. In 1982, he founded American Innovision, an image analysis company that designed and built software and hardware, and configured complete application systems. He acted as owner, president, and vice president of Research and Development for American Innovision, until its sale to Oncor Instrument Systems in 1992. He was the principal designer and lead programmer A lead programmer is a software engineer in charge of one or more software projects. Alternative titles include Development Lead, Technical Lead, Senior Software Engineer, Software Design Engineer Lead (SDE Lead), Software Manager for all of American Innovision's products, and managed all phases of product development from initial concept to market launch and customer service. Torre-Bueno received a Ph.D. in physiology, behavior and genetics with an emphasis on instrument design from Rockefeller University Rockefeller University, philanthropic organization in New York City, founded 1901 as the Rockefeller Institute for Medical Research by John D. Rockefeller for furthering medical science and its allied subjects and to make knowledge of these subjects available to the in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , and a bachelor of science Noun 1. Bachelor of Science - a bachelor's degree in science BS, SB bachelor's degree, baccalaureate - an academic degree conferred on someone who has successfully completed undergraduate studies degree in biology and psychology from the State University of New York (body) State University of New York - (SUNY) The public university system of New York State, USA, with campuses throughout the state. at Stony Brook Stony Brook may refer to: Massachusetts:
In his new role, Torre-Bueno is responsible for leading the R&D team in achieving the company's objective of developing high-value applications for the ACIS platform. He currently resides with his family in Encinitas. About ChromaVision Medical Systems ChromaVision Medical Systems manufactures and markets an advanced cellular imaging system designed to advance the detection, diagnosis and treatment of cellular disease. The Automated Cellular Imaging Systems (ACIS(TM)) combines proprietary, color-based imaging technology with automated microscopy to bring unprecedented sensitivity, accuracy and reproducibility to cancer, infections disease and genetic cell-based diagnostics. ChromaVision currently markets its products to physicians and researchers in university medical centers and commercial laboratories throughout the world. ChromaVision Medical Systems was formed by XL Vision Inc., and is a Safeguard Scientifics Inc. (NYSE NYSE See: New York Stock Exchange : SFE See Sydney Futures Exchange. ) partnership company. For more information on ChromaVision Medical Systems, visit the company's Web site at http://www.chromavision.com. The statements contained herein regarding ChromaVision Medical Systems contain forward-looking statements that involve risks and uncertainty. Future events and the company's actual results could differ materially from the results reflected in these forward-looking statements. Factors that might cause such a difference include, but are not limited to, uncertainty of success in developing any new diagnostic test, failure to obtain FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. clearance or approval for particular applications and dependence on third parties for clinical testing. ACIS is a trademark of ChromaVision Medical Systems Inc. |
|
||||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion